The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
“We are able to purchase drugs on a federal pricing program called 340 B. Starting in July, we noticed a dramatic increase in our insulin costs." A disproportionate share hospital treats a ...
SAN ANTONIO – The City of San Antonio and H-E-B launched the Diabetes Insulin Assistance Program to help residents struggling with the high cost of insulin. The program aims to make diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback